Summary

Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus—associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm.

See related article by Reid et al., p. xxx

This content is only available via PDF.
You do not currently have access to this content.